Volume without Value: The Empty Metrics of Pain Medicine Social Media Influence

Le résumé fourni par la source

Across social media platforms such as Instagram, X, and LinkedIn, a familiar post now permeates the interventional pain landscape."Congratulations, Dr. Smith, for implanting 300 patients with the XXX system".However, there is no mention of patient-related outcomes, complications, or long-term follow-up.Instead, there is a myopic focus on case counts that fails to acknowledge the impact on patient lives or functionality.The accompanying photo is usually the same: a smiling doctor standing shoulder to shoulder with a device representative, surrounded by stacks of opened device boxes used as free advertising.It looks like a celebration but feels more like a product launch.The focus is on marketing, not medicine.These congratulatory posts have become a form of social currency, increasing professional visibility within the interventional pain community.Companies share them because they are easy to distribute, simple to measure, free, and quick to praise with comments, likes, and virtual engagement.Device representatives, managers, and executives all give themselves a proverbial pat on the back for another successful case, another sale.What is not mentioned is that these posts distort reality and shift attention away from meaningful clinical value toward throughput.When achievement is judged by quantity rather than quality, pain medicine risks losing sight of accepted clinical aims as well as its ethical foundation.At the same time, we should acknowledge that higher procedural volumes have been associated with improved outcomes and lower complication rates across several procedural disciplines.For example, procedural proficiency has been demonstrated in the spine surgery literature and reflects the value of experience and repetition.1,2 Volume itself is not inherently harmful and can even correlate with enhanced safety and quality.The concern raised in this editorial is not the act of performing advanced procedures or even performing them frequently.Rather, it is the public celebration of volume as the leading indicator of quality in the absence of patient-centered metrics.Also, of concern is who is pushing the narrative.With the rise of social media and its popularity among clinicians, visuals and messaging carry more weight than ever, particularly in a rapidly changing field.The cult of personality in a digital and social media age is now unavoidable.Volume-driven virtual validation parallels another trend: the rise of industry-sponsored centers of excellence (COEs).These COE designations originally described multidisciplinary programs anchored in evidence-based care.3 Many current iterations, however, rely on vague or volume-focused criteria, such as procedure counts, participation in company training, and product use, rather than on medical outcomes, complication rates, or independent oversight.4 When entities that develop and promote therapies also define the standards of excellence, the result is a feedback loop that risks promoting scale over quality.Despite this challenging landscape, we also recognize that social media content has the potential to play a constructive role.Increased public awareness of interventional pain therapies supports patient access, increases understanding, and contributes to competitive innovation.5 The potential positive impact of visibility does not diminish the need for accuracy or context, but it does highlight that not all public communication is inherently problematic.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.